Array Biopharma Inc (ARRY.OQ)
ARRY.OQ on NASDAQ Stock Exchange Global Market
6.99USD
11:03am EDT
6.99USD
11:03am EDT
Price Change (% chg)
$0.33 (+4.95%)
$0.33 (+4.95%)
Prev Close
$6.66
$6.66
Open
$6.80
$6.80
Day's High
$6.99
$6.99
Day's Low
$6.76
$6.76
Volume
273,510
273,510
Avg. Vol
422,320
422,320
52-wk High
$6.99
$6.99
52-wk Low
$3.26
$3.26
About
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. The drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target... (more)
Overall
| Beta: | 1.73 |
| Market Cap (Mil.): | $777.73 |
| Shares Outstanding (Mil.): | 116.78 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ARRY.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -0.48 | -- | -- |
| ROI: | -107.17 | -2.58 | 18.76 |
| ROE: | -- | -2.66 | 19.59 |
Array asthma drug meets main goal in mid-stage study
- Array Biopharma Inc said one of its drugs met the main goal of improving lung function in a mid-stage study among patients with mild to moderate persistent allergic asthma.
Competitors
| Price | Change | |
|---|---|---|
| Pfizer Inc. (PFE.N) | $29.16 | -0.07 |
| Johnson & Johnson (JNJ.N) | $93.91 | +0.41 |
| AstraZeneca plc (AZN.L) | 3,318.00p | -17.00 |
| GlaxoSmithKline plc (GSK.L) | 1,706.75p | +22.50 |
| ArQule, Inc. (ARQL.OQ) | $2.69 | +0.02 |
| Ariad Pharmaceuticals, Inc. (ARIA.OQ) | $18.85 | +0.27 |
| Theravance Inc (THRX.OQ) | $38.25 | -0.31 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Edison Investment Research
|
$10.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

